﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.irs.gov/efile" returnVersion="2012v2.1">
  <ReturnHeader binaryAttachmentCount="0">
    <Timestamp>2013-08-14T08:20:22-05:00</Timestamp>
    <TaxPeriodEndDate>2012-12-31</TaxPeriodEndDate>
    <PreparerFirm>
      <EIN>721396621</EIN>
      <PreparerFirmBusinessName>
        <BusinessNameLine1>CARR RIGGS &amp; INGRAM LLC</BusinessNameLine1>
      </PreparerFirmBusinessName>
      <PreparerFirmUSAddress>
        <AddressLine1>4010 NW 25TH PLACE</AddressLine1>
        <City>GAINESVILLE</City>
        <State>FL</State>
        <ZIPCode>32606</ZIPCode>
      </PreparerFirmUSAddress>
    </PreparerFirm>
    <ReturnType>990</ReturnType>
    <TaxPeriodBeginDate>2012-01-01</TaxPeriodBeginDate>
    <Filer>
      <EIN>593471957</EIN>
      <Name>
        <BusinessNameLine1>FOUNDATION FOR APPLIED MOLECULAR EVOLUTION INC</BusinessNameLine1>
      </Name>
      <NameControl>FOUN</NameControl>
      <Phone>3522717005</Phone>
      <USAddress>
        <AddressLine1>PO BOX 13174</AddressLine1>
        <City>GAINESVILLE</City>
        <State>FL</State>
        <ZIPCode>32604</ZIPCode>
      </USAddress>
    </Filer>
    <Officer>
      <Name>STEVEN BENNER</Name>
      <Title>PRESIDENT</Title>
      <Phone>3522717005</Phone>
      <DateSigned>2013-08-12</DateSigned>
      <AuthorizeThirdParty>1</AuthorizeThirdParty>
    </Officer>
    <Preparer>
      <Name>FRANK WALTERS CPA</Name>
      <PTIN>P00316108</PTIN>
      <Phone>3523726300</Phone>
    </Preparer>
    <TaxYear>2012</TaxYear>
    <BuildTS>2016-02-24 21:20:13Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCount="8">
    <IRS990 documentId="RetDoc1038000001" referenceDocumentId="RetDoc1044400001">
      <NameOfPrincipalOfficerPerson>STEVEN BENNER</NameOfPrincipalOfficerPerson>
      <AddressPrincipalOfficerUS>
        <AddressLine1>PO BOX 13174</AddressLine1>
        <City>GAINESVILLE</City>
        <State>FL</State>
        <ZIPCode>32604</ZIPCode>
      </AddressPrincipalOfficerUS>
      <GrossReceipts>3239463</GrossReceipts>
      <GroupReturnForAffiliates>0</GroupReturnForAffiliates>
      <Organization501c3>X</Organization501c3>
      <WebSite>WWW.FFAME.ORG</WebSite>
      <TypeOfOrganizationCorporation>X</TypeOfOrganizationCorporation>
      <YearFormation>1997</YearFormation>
      <StateLegalDomicile>FL</StateLegalDomicile>
      <ActivityOrMissionDescription>THE FOUNDATION PROVIDES AN INNOVATIVE ENVIRONMENT TO HOST THE SCIENTIFIC AND TECHNOLOGICAL RESEARCH OF A SMALL GROUP OF SELECTED MOLECULAR AND LIFE SCIENTISTS TO MEET OPPORTUNITES IN COMMERCE AND MEDICINE.</ActivityOrMissionDescription>
      <NbrVotingMembersGoverningBody>5</NbrVotingMembersGoverningBody>
      <NbrIndependentVotingMembers>3</NbrIndependentVotingMembers>
      <TotalNbrEmployees>31</TotalNbrEmployees>
      <TotalNbrVolunteers>0</TotalNbrVolunteers>
      <TotalGrossUBI>0</TotalGrossUBI>
      <NetUnrelatedBusinessTxblIncome>0</NetUnrelatedBusinessTxblIncome>
      <ContributionsGrantsPriorYear>2654145</ContributionsGrantsPriorYear>
      <ContributionsGrantsCurrentYear>3216510</ContributionsGrantsCurrentYear>
      <ProgramServiceRevenuePriorYear>18003</ProgramServiceRevenuePriorYear>
      <ProgramServiceRevenueCY>21505</ProgramServiceRevenueCY>
      <InvestmentIncomePriorYear>1608</InvestmentIncomePriorYear>
      <InvestmentIncomeCurrentYear>373</InvestmentIncomeCurrentYear>
      <OtherRevenuePriorYear>26280</OtherRevenuePriorYear>
      <OtherRevenueCurrentYear>1075</OtherRevenueCurrentYear>
      <TotalRevenuePriorYear>2700036</TotalRevenuePriorYear>
      <TotalRevenueCurrentYear>3239463</TotalRevenueCurrentYear>
      <GrantsAndSimilarAmntsPriorYear>0</GrantsAndSimilarAmntsPriorYear>
      <GrantsAndSimilarAmntsCY>0</GrantsAndSimilarAmntsCY>
      <BenefitsPaidToMembersPriorYear>0</BenefitsPaidToMembersPriorYear>
      <BenefitsPaidToMembersCY>0</BenefitsPaidToMembersCY>
      <SalariesEtcPriorYear>1467761</SalariesEtcPriorYear>
      <SalariesEtcCurrentYear>1839484</SalariesEtcCurrentYear>
      <TotalProfFundrsngExpPriorYear>0</TotalProfFundrsngExpPriorYear>
      <TotalProfFundrsngExpCY>0</TotalProfFundrsngExpCY>
      <TotalFundrsngExpCurrentYear>0</TotalFundrsngExpCurrentYear>
      <OtherExpensePriorYear>1389199</OtherExpensePriorYear>
      <OtherExpensesCurrentYear>1332382</OtherExpensesCurrentYear>
      <TotalExpensesPriorYear>2856960</TotalExpensesPriorYear>
      <TotalExpensesCurrentYear>3171866</TotalExpensesCurrentYear>
      <RevenuesLessExpensesPriorYear>-156924</RevenuesLessExpensesPriorYear>
      <RevenuesLessExpensesCY>67597</RevenuesLessExpensesCY>
      <TotalAssetsBOY>992523</TotalAssetsBOY>
      <TotalAssetsEOY>1456670</TotalAssetsEOY>
      <TotalLiabilitiesBOY>530141</TotalLiabilitiesBOY>
      <TotalLiabilitiesEOY>926691</TotalLiabilitiesEOY>
      <NetAssetsOrFundBalancesBOY>462382</NetAssetsOrFundBalancesBOY>
      <NetAssetsOrFundBalancesEOY>529979</NetAssetsOrFundBalancesEOY>
      <InfoInScheduleOPartIII>X</InfoInScheduleOPartIII>
      <MissionDescription>THE FOUNDATION PROVIDES AN INNOVATIVE ENVIRONMENT TO HOST THE SCIENTIFIC AND TECHNOLOGICAL RESEARCH OF A SMALL GROUP OF SELECTED MOLECULAR AND LIFE SCIENTISTS TO MEET OPPORTUNITES IN COMMERCE AND MEDICINE.</MissionDescription>
      <SignificantNewProgramServices>0</SignificantNewProgramServices>
      <SignificantChange>0</SignificantChange>
      <Expense>2770148</Expense>
      <Revenue>22580</Revenue>
      <Description>THE ORGANIZATION HAS PREPARED A NUMBER OF RESEARCH PROJECTS - SEE SCHEDULE O FOR DETAILS:R01HG004647CHEMISTRY TO IMPROVE HUMAN GENOMIC ARRAY ANALYSIS ARCHITECTURESTHIS PROJECT INVOLVES WORK TO APPLY INNOVATIVE CHEMICAL TOOLS TO DEVELOP SOLID BASED SUPPORTS FOR HIGH THROUGHPUT GENOMIC ANALYSIS.R01HG004831NEAR TERM DEVELOPMENT OF REAGENTS AND ENZYMES FOR GENOME SEQUENCINGTHIS PROJECT INVOLVES WORK TO DEVELOP REAGENTS TO FACILITATE WHOLE GENOME ANALYSIS THROUGH A BINNING STRATEGY THAT COMBINES ARTIFICIALLY EXPANDED GENETIC INFORMATION SYSTEMS, SELF-AVOIDING MOLECULAR RECOGNITION SYSTEMS, SNAP2 DYNAMIC COMBINATORIAL CHEMISTRY, AND SEQUENCE THE BINNED SEQUENCES. R01GM086617BIOCHEMICAL &amp; PHARMACOLOGICAL STUDIES OF HUMAN MEMBRANE PROGESTERONE RECEPTORSTHIS PROJECT INVOLVES WORK TO EXPAND OUR UNDERSTANDING OF HOW HUMAN CELLS SENSE AND RESPOND TO STEROID HORMONES.2R42HG004589-02STTR PHASE 2 (SUBCONTRACT) MULTIPURPOSE REVERSIBLE TERMINATORSTHIS PROJECT INVOLVES WORK TO TRANSFER TECHNOLOGY FROM THE FOUNDATION FOR APPLIED MOLECULAR EVOLUTION TO FIREBIRD BIOMOLECULAR SCIENCES LLC, TO BUILD A CATALOG OF REAGENTS AND KITS TO SUPPORT MULTIPLEXED NUCLEIC ACID ANALYSES.R01AA017723ALCOHOL METABOLISM, PRIMATE EVOLUTION, AND PALEOGENETICS: AN INCLUSIVE PARADIGMTHIS PROJECT INVOLVED WORK APPLYING PALEOGENETICS AND GENOMICS TO FAMILIES OF GENES AND PROTEINS IMPORTANT IN HUMAN ALCOHOLISM, IN A COLLABORATIVE PROJECT WITH CRYSTALLOGRAPHERS AT INDIANA UNIVERSITY.HDTRA1-08-1-0052SYNTHETIC SUBSTITUTES FOR DNATHIS PROJECT INVOLVES WORK DEVELOPING THE BASIC SCIENCE RELATING TO NUCLEIC ACID CHEMISTRY, ESPECIALLY AS IT RELATES TO COMPUTATIONAL ANALYSIS OF DNA STRUCTURE AND NUCLEIC ACID REPLACEMENTS OPERATING IN UNUSUAL ENVIRONMENTS.NNX08AO23G NASAPREBIOTIC ROUTES TO CARBOHYDRATES INVOLVING BORATE MINERALSTHIS PROJECT INVOLVES WORK THAT TO UNDERSTAND HOW MINERALS MAY HAVE GUIDED THE REACTIVITY OF CARBONYL GROUPS TO GENERATE RIBOSE AND OTHER COMPONENTS OF RNA IN AN RNA-FIRST SCENARIO FOR THE ORIGIN OF LIFE.RSA1371457 NASA ASTROBIOLOGY SUBCONTRACT FROM THE JET PROPULSION LABTITAN AS A PREBIOTIC CHEMICAL SYSTEMTHIS PROJECT INVOLVES WORK TO UNDERSTAND HOW TITAN MIGHT SERVE AS A MODEL FOR PREBIOTIC EARTH, WHETHER IT MIGHT CURRENTLY HOST LIFE THAT LIVES IN UNUSUAL ENVIRONMENTS, AND TO OTHERWISE INFORM NASA MISSIONS TO THIS MOON OF SATURN.NNX10AT28G NASA EXOBIOLOGYLANDSCAPES IN CATALYTIC NUCLEIC ACIDSTHIS PROJECT INVOLVES WORK TO GENERATE QUANTITATIVE EXPERIMENTAL DATA TO DETERMINE WHERE TWO BIOPOLYMERS (DNA AND RNA) KNOWN TO BE ABLE TO SUPPORT BOTH GENETICS AND CATALYSIS LIE BETWEEN THESE EXTREMES.HR0011-12-C-0064REENGINEERING DNA TO ENABLE ULTRA LARGE SCALE DNA ASSEMBLYTHIS PROJECT INVOLVES WORK TO DEVELOP AND APPLY AN ENGINEERING FRAMEWORK TO BIOLOGY THAT DECOUPLES BIOLOGICAL DESIGN FROM FABRICATION, YIELDS DESIGN RULES AND TOOLS, AND MANAGES BIOLOGICAL COMPLEXITY THROUGH ABSTRACTION AND STANDARDIZATION.N66001-12-C-4019SYNTHETIC BIOLOGY TO CREATE BIOHAZARD-FREE PLATFORMS FOR BIOTECHNOLOGYTHIS PROJECT INVOLVES WORK TO AUGMENT/REPLACE BIOSECURITY RESTRICTIONS DURING GENETIC ENGINEERING AND SYNTHETIC BIOLOGY RESEARCH BY ENSURING BIOSAFETY AND BIOSECURITY AT THE LEVEL OF THE ENGINEERED ORGANISM BY LAYING THE GROUNDS FOR A XENOBIOLOGY, WHICH INCLUDES LIVING SYSTEMS ABLE TO GROW, DIVIDE, AND EVOLVE USING UNNATURAL DNA BUILT FROM AN ARTIFICIALLY EXPANDED GENETIC INFORMATION SYSTEM (AEGIS).R01AI098616IMPROVED HIV ASSAYS BY COMBINING FOUR INNOVATIONS IN NUCLEIC ACID CHEMISTRYTHIS PROJECT INVOLVES WORK TO IMPROVE HIV DIAGNOSTIC TOOLS, ESPECIALLY TO DISTINGUISH CHRONIC FROM RECENT INFECTIONS OF THE AIDS-CAUSING VIRUS.R01GM081527ARTIFICIAL GENETIC SYSTEMSTHIS PROJECT INVOLVES WORK TO DEVELOP THE FIELD OF "SYNTHETIC BIOLOGY", INVENTED IN PART IN THE BENNER LABORATORY. THE PRINCIPAL AIM OF SYNTHETIC BIOLOGISTS IS TO DEVELOP ARTIFICIAL CHEMICAL SYSTEMS THAT REPRODUCE THE "EMERGENT" PROPERTIES OF LIVING SYSTEMS, LEARNING ABOUT LIFE BY BUILDING IT "FROM THE GROUND UP".W911NF-12-C-0059 (SUBCONTRACT)DESIGNABLE REAGENTS AND SOFTWARE FOR DNA-BASED NANO-SENSOR ARCHITECTURESTHIS PROJECT INVOLVES WORK TO USE BIOMIMETIC NUCLEIC ACIDS TO CREATE NANO-STRUCTURES THAT CAN DETECT AND SIGNAL THE PRESENCE OF TARGET MOLECULES.HR0011-11-2-0018KNOWLEDGE-BASED REAGENTS FOR DNA DIAGNOSTICS: MEETING DARPAS PERFORMANCE METRICSTHIS PROJECT INVOLVES WORK TO DEVELOP REAGENT-ENZYME COMBINATIONS TO SUPPORT POINT-OF-CARE DIAGNOSTICS TOOLS FOR INFECTIOUS AGENTS. HERE, THE NUCLEIC ACIDS OF THE INFECTIOUS AGENTS ARE THE TARGETS.C13K11520 (K00183) SUBCONTRACTIROTS: INOPERABLE ROBUST ORTHOGONAL TRANSLATION SYSTEMTHIS PROJECT INVOLVES WORK TO SUPPORT TEAMS AT YALE, NORTHWESTERN, AND AGILENT SEEKING TO INCREASE THE NUMBER OF ENCODED AMINO ACIDS IN PROTEINS THAT ARE TRANSLATED IN VITRO AND IN VIVO.HDTRA-13-1-0004APTAMERS FROM ARTIFICIAL GENETIC SYSTEMSTHIS PROJECT INVOLVES WORK TO DEVELOP TECHNOLOGY TO CREATE BINDERS ON DEMAND IN THE FORM OF NUCLEIC ACID ANALOGS CONTAINING ADDITIONAL NUCLEIC ACID BUILDING BLOCKS.</Description>
      <TotalProgramServiceExpense>2770148</TotalProgramServiceExpense>
      <DescribedIn501C3 referenceDocumentId="RetDoc1039100001">1</DescribedIn501C3>
      <ScheduleBRequired referenceDocumentId="RetDoc1234500001">1</ScheduleBRequired>
      <PoliticalActivities>0</PoliticalActivities>
      <LobbyingActivities>0</LobbyingActivities>
      <SubjectToProxyTax>0</SubjectToProxyTax>
      <DonorAdvisedFunds referenceDocumentId="RetDoc1040000001">0</DonorAdvisedFunds>
      <ConservationEasements referenceDocumentId="RetDoc1040000001">0</ConservationEasements>
      <CollectionsOfArt referenceDocumentId="RetDoc1040000001">0</CollectionsOfArt>
      <CreditCounseling referenceDocumentId="RetDoc1040000001">0</CreditCounseling>
      <TermOrPermanentEndowments referenceDocumentId="RetDoc1040000001">0</TermOrPermanentEndowments>
      <ReportLandBldgEquip referenceDocumentId="RetDoc1040000001">1</ReportLandBldgEquip>
      <ReportInvestOthSecurities referenceDocumentId="RetDoc1040000001">0</ReportInvestOthSecurities>
      <ReportProgRelInvest referenceDocumentId="RetDoc1040000001">0</ReportProgRelInvest>
      <ReportOtherAssets referenceDocumentId="RetDoc1040000001">0</ReportOtherAssets>
      <ReportOtherLiabilities referenceDocumentId="RetDoc1040000001">1</ReportOtherLiabilities>
      <ReportFin48Footnote referenceDocumentId="RetDoc1040000001">1</ReportFin48Footnote>
      <IndependentAuditFinancialStmt referenceDocumentId="RetDoc1040000001">1</IndependentAuditFinancialStmt>
      <ConsolidatedAuditFinancialStmt referenceDocumentId="RetDoc1040000001">0</ConsolidatedAuditFinancialStmt>
      <School>0</School>
      <ForeignOffice>0</ForeignOffice>
      <ForeignActivities>0</ForeignActivities>
      <MoreThan5000KToOrganizations>0</MoreThan5000KToOrganizations>
      <MoreThan5000KToIndividuals>0</MoreThan5000KToIndividuals>
      <ProfessionalFundraising>0</ProfessionalFundraising>
      <FundraisingActivities>0</FundraisingActivities>
      <Gaming>0</Gaming>
      <Hospital>0</Hospital>
      <GrantsToOrganizations>0</GrantsToOrganizations>
      <GrantsToIndividuals>0</GrantsToIndividuals>
      <ScheduleJRequired referenceDocumentId="RetDoc1042400001">1</ScheduleJRequired>
      <TaxExemptBonds>0</TaxExemptBonds>
      <ExcessBenefitTransaction referenceDocumentId="RetDoc1042800001">0</ExcessBenefitTransaction>
      <PriorExcessBenefitTransaction referenceDocumentId="RetDoc1042800001">0</PriorExcessBenefitTransaction>
      <LoanToOfficerOrDQP referenceDocumentId="RetDoc1042800001">0</LoanToOfficerOrDQP>
      <GrantToRelatedPerson referenceDocumentId="RetDoc1042800001">0</GrantToRelatedPerson>
      <BsnssRltnshpWithOrganization referenceDocumentId="RetDoc1042800001">1</BsnssRltnshpWithOrganization>
      <BsnssRltnshpThruFamilyMember referenceDocumentId="RetDoc1042800001">1</BsnssRltnshpThruFamilyMember>
      <OfficerEntityWithBsnssRltnshp referenceDocumentId="RetDoc1042800001">1</OfficerEntityWithBsnssRltnshp>
      <DeductibleNonCashContributions>0</DeductibleNonCashContributions>
      <DeductibleContributionsOfArt>0</DeductibleContributionsOfArt>
      <Terminated>0</Terminated>
      <PartialLiquidation>0</PartialLiquidation>
      <DisregardedEntity referenceDocumentId="RetDoc1043500001">0</DisregardedEntity>
      <RelatedEntity referenceDocumentId="RetDoc1043500001">1</RelatedEntity>
      <RelatedOrgControlledEntity>0</RelatedOrgControlledEntity>
      <TransfersToExemptNonChrtblOrg referenceDocumentId="RetDoc1043500001">0</TransfersToExemptNonChrtblOrg>
      <ActivitiesConductedPartnership referenceDocumentId="RetDoc1043500001">0</ActivitiesConductedPartnership>
      <ScheduleORequired>1</ScheduleORequired>
      <NumberFormsTransmittedWith1096>8</NumberFormsTransmittedWith1096>
      <NumberW2GIncluded>0</NumberW2GIncluded>
      <ComplianceWithBackupWitholding>1</ComplianceWithBackupWitholding>
      <NumberOfEmployees>31</NumberOfEmployees>
      <EmploymentTaxReturnsFiled>1</EmploymentTaxReturnsFiled>
      <UnrelatedBusinessIncome>0</UnrelatedBusinessIncome>
      <ForeignFinancialAccount>0</ForeignFinancialAccount>
      <ProhibitedTaxShelterTrans>0</ProhibitedTaxShelterTrans>
      <TaxablePartyNotification>0</TaxablePartyNotification>
      <NonDeductibleContributions>0</NonDeductibleContributions>
      <QuidProQuoContributions>0</QuidProQuoContributions>
      <Form8282PropertyDisposedOf>0</Form8282PropertyDisposedOf>
      <FundsToPayPremiums>0</FundsToPayPremiums>
      <PremiumsPaid>0</PremiumsPaid>
      <IndoorTanningServices>0</IndoorTanningServices>
      <InfoInScheduleOPartVI>X</InfoInScheduleOPartVI>
      <NbrVotingGoverningBodyMembers>5</NbrVotingGoverningBodyMembers>
      <NumberIndependentVotingMembers>3</NumberIndependentVotingMembers>
      <FamilyOrBusinessRelationship>1</FamilyOrBusinessRelationship>
      <DelegationOfManagementDuties>0</DelegationOfManagementDuties>
      <ChangesToOrganizingDocs>0</ChangesToOrganizingDocs>
      <MaterialDiversionOrMisuse>0</MaterialDiversionOrMisuse>
      <MembersOrStockholders>0</MembersOrStockholders>
      <ElectionOfBoardMembers>0</ElectionOfBoardMembers>
      <DecisionsSubjectToApproval>0</DecisionsSubjectToApproval>
      <MinutesOfGoverningBody>1</MinutesOfGoverningBody>
      <MinutesOfCommittees>1</MinutesOfCommittees>
      <OfficerMailingAddress>0</OfficerMailingAddress>
      <LocalChapters>0</LocalChapters>
      <Form990ProvidedToGoverningBody>1</Form990ProvidedToGoverningBody>
      <ConflictOfInterestPolicy>1</ConflictOfInterestPolicy>
      <AnnualDisclosureCoveredPersons>1</AnnualDisclosureCoveredPersons>
      <RegularMonitoringEnforcement>1</RegularMonitoringEnforcement>
      <WhistleblowerPolicy>1</WhistleblowerPolicy>
      <DocumentRetentionPolicy>1</DocumentRetentionPolicy>
      <CompensationProcessCEO>1</CompensationProcessCEO>
      <CompensationProcessOther>1</CompensationProcessOther>
      <InvestmentInJointVenture>0</InvestmentInJointVenture>
      <UponRequest>X</UponRequest>
      <TheBooksAreInCareOf>
        <NameBusiness>
          <BusinessNameLine1>ROMAINE HUGHES</BusinessNameLine1>
        </NameBusiness>
        <TelephoneNumber>3522717005</TelephoneNumber>
        <AddressUS>
          <AddressLine1>PO BOX 13174</AddressLine1>
          <City>GAINESVILLE</City>
          <State>FL</State>
          <ZIPCode>32604</ZIPCode>
        </AddressUS>
      </TheBooksAreInCareOf>
      <Form990PartVIISectionA>
        <NamePerson>STEVEN BENNER</NamePerson>
        <Title>DIRECTOR</Title>
        <AverageHoursPerWeek>40.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <Officer>X</Officer>
        <ReportableCompFromOrganization>170303</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>STEPHEN CHAMBERLIN</NamePerson>
        <Title>DIRECTOR</Title>
        <AverageHoursPerWeek>40.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>19000</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>NIGEL RICHARDS</NamePerson>
        <Title>DIRECTOR</Title>
        <AverageHoursPerWeek>1.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>1000</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>ANDREW ELLINGTON</NamePerson>
        <Title>DIRECTOR</Title>
        <AverageHoursPerWeek>1.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>BEVERLY A SANDERS</NamePerson>
        <Title>DIRECTOR</Title>
        <AverageHoursPerWeek>1.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <TotalReportableCompFromOrg>190303</TotalReportableCompFromOrg>
      <TotalReportableCompFrmRltdOrgs>0</TotalReportableCompFrmRltdOrgs>
      <TotalOtherCompensation>0</TotalOtherCompensation>
      <NumberIndividualsGT100K>1</NumberIndividualsGT100K>
      <FormersListed>0</FormersListed>
      <TotalCompGT150K>1</TotalCompGT150K>
      <CompensationFromOtherSources>0</CompensationFromOtherSources>
      <NumberOfContractorsGT100K>0</NumberOfContractorsGT100K>
      <GovernmentGrants>3216510</GovernmentGrants>
      <TotalContributions>3216510</TotalContributions>
      <ProgramServiceRevenue>
        <Description>BOOK SALES</Description>
        <BusinessCode>541700</BusinessCode>
        <TotalRevenueColumn>13221</TotalRevenueColumn>
        <RelatedOrExemptFunctionIncome>13221</RelatedOrExemptFunctionIncome>
      </ProgramServiceRevenue>
      <ProgramServiceRevenue>
        <Description>NUCLEIC ACIDS LICENSIN</Description>
        <BusinessCode>541700</BusinessCode>
        <TotalRevenueColumn>8284</TotalRevenueColumn>
        <RelatedOrExemptFunctionIncome>8284</RelatedOrExemptFunctionIncome>
      </ProgramServiceRevenue>
      <TotalProgramServiceRevenue>21505</TotalProgramServiceRevenue>
      <InvestmentIncome>
        <TotalRevenueColumn>373</TotalRevenueColumn>
        <ExclusionAmount>373</ExclusionAmount>
      </InvestmentIncome>
      <OtherRevenueMisc>
        <Description>OTHER INCOME</Description>
        <BusinessCode>541700</BusinessCode>
        <TotalRevenueColumn>1075</TotalRevenueColumn>
        <RelatedOrExemptFunctionIncome>1075</RelatedOrExemptFunctionIncome>
      </OtherRevenueMisc>
      <TotalOtherRevenue>1075</TotalOtherRevenue>
      <TotalRevenue>
        <TotalRevenueColumn>3239463</TotalRevenueColumn>
        <RelatedOrExemptFunctionIncome>22580</RelatedOrExemptFunctionIncome>
        <UnrelatedBusinessRevenue>0</UnrelatedBusinessRevenue>
        <ExclusionAmount>373</ExclusionAmount>
      </TotalRevenue>
      <CompCurrentOfficersDirectors>
        <Total>190303</Total>
        <ProgramServices>190303</ProgramServices>
      </CompCurrentOfficersDirectors>
      <OtherSalariesAndWages>
        <Total>1389538</Total>
        <ProgramServices>1168306</ProgramServices>
        <ManagementAndGeneral>221232</ManagementAndGeneral>
      </OtherSalariesAndWages>
      <OtherEmployeeBenefits>
        <Total>136598</Total>
        <ProgramServices>99160</ProgramServices>
        <ManagementAndGeneral>37438</ManagementAndGeneral>
      </OtherEmployeeBenefits>
      <PayrollTaxes>
        <Total>123045</Total>
        <ProgramServices>110186</ProgramServices>
        <ManagementAndGeneral>12859</ManagementAndGeneral>
      </PayrollTaxes>
      <FeesForServicesLegal>
        <Total>12566</Total>
        <ProgramServices>12347</ProgramServices>
        <ManagementAndGeneral>219</ManagementAndGeneral>
      </FeesForServicesLegal>
      <FeesForServicesAccounting>
        <Total>44144</Total>
        <ManagementAndGeneral>44144</ManagementAndGeneral>
      </FeesForServicesAccounting>
      <OfficeExpenses>
        <Total>538794</Total>
        <ProgramServices>514435</ProgramServices>
        <ManagementAndGeneral>24359</ManagementAndGeneral>
      </OfficeExpenses>
      <InformationTechnology>
        <Total>30207</Total>
        <ProgramServices>2196</ProgramServices>
        <ManagementAndGeneral>28011</ManagementAndGeneral>
      </InformationTechnology>
      <Royalties>
        <Total>206602</Total>
        <ProgramServices>190113</ProgramServices>
        <ManagementAndGeneral>16489</ManagementAndGeneral>
      </Royalties>
      <Travel>
        <Total>26127</Total>
        <ProgramServices>24282</ProgramServices>
        <ManagementAndGeneral>1845</ManagementAndGeneral>
      </Travel>
      <DepreciationDepletion>
        <Total>180841</Total>
        <ProgramServices>175588</ProgramServices>
        <ManagementAndGeneral>5253</ManagementAndGeneral>
      </DepreciationDepletion>
      <OtherExpenses>
        <Description>SUBCONTRACTORS</Description>
        <Total>214705</Total>
        <ProgramServices>212405</ProgramServices>
        <ManagementAndGeneral>2300</ManagementAndGeneral>
      </OtherExpenses>
      <OtherExpenses>
        <Description>PERSONNEL EXPENSES</Description>
        <Total>39547</Total>
        <ProgramServices>39547</ProgramServices>
      </OtherExpenses>
      <OtherExpenses>
        <Description>EQUIPMENT RENTAL &amp; MAIN</Description>
        <Total>30791</Total>
        <ProgramServices>30124</ProgramServices>
        <ManagementAndGeneral>667</ManagementAndGeneral>
      </OtherExpenses>
      <OtherExpenses>
        <Description>OTHER</Description>
        <Total>8058</Total>
        <ProgramServices>1156</ProgramServices>
        <ManagementAndGeneral>6902</ManagementAndGeneral>
      </OtherExpenses>
      <TotalFunctionalExpenses>
        <Total>3171866</Total>
        <ProgramServices>2770148</ProgramServices>
        <ManagementAndGeneral>401718</ManagementAndGeneral>
        <Fundraising>0</Fundraising>
      </TotalFunctionalExpenses>
      <CashNonInterestBearing>
        <BOY>79454</BOY>
        <EOY>78018</EOY>
      </CashNonInterestBearing>
      <SavingsAndTempCashInvestments>
        <BOY>384642</BOY>
        <EOY>503730</EOY>
      </SavingsAndTempCashInvestments>
      <PledgesAndGrantsReceivable>
        <BOY>61667</BOY>
        <EOY>339005</EOY>
      </PledgesAndGrantsReceivable>
      <LandBuildingsEquipmentBasis>1445577</LandBuildingsEquipmentBasis>
      <LandBldgEquipmentAccumDeprec>910868</LandBldgEquipmentAccumDeprec>
      <LandBuildingsEquipmentBasisNet>
        <BOY>465552</BOY>
        <EOY>534709</EOY>
      </LandBuildingsEquipmentBasisNet>
      <OtherAssetsTotal>
        <BOY>1208</BOY>
        <EOY>1208</EOY>
      </OtherAssetsTotal>
      <TotalAssets>
        <BOY>992523</BOY>
        <EOY>1456670</EOY>
      </TotalAssets>
      <AccountsPayableAccruedExpenses>
        <BOY>95817</BOY>
        <EOY>14083</EOY>
      </AccountsPayableAccruedExpenses>
      <OtherLiabilities>
        <BOY>434324</BOY>
        <EOY>912608</EOY>
      </OtherLiabilities>
      <TotalLiabilities>
        <BOY>530141</BOY>
        <EOY>926691</EOY>
      </TotalLiabilities>
      <FollowSFAS117>X</FollowSFAS117>
      <UnrestrictedNetAssets>
        <BOY>462382</BOY>
        <EOY>529979</EOY>
      </UnrestrictedNetAssets>
      <TotalNetAssetsFundBalances>
        <BOY>462382</BOY>
        <EOY>529979</EOY>
      </TotalNetAssetsFundBalances>
      <TotalLiabNetAssetsFundBalances>
        <BOY>992523</BOY>
        <EOY>1456670</EOY>
      </TotalLiabNetAssetsFundBalances>
      <ReconcilationRevenueExpenses>67597</ReconcilationRevenueExpenses>
      <ReconcilationOtherChanges>0</ReconcilationOtherChanges>
      <InfoInScheduleOPartXII>X</InfoInScheduleOPartXII>
      <MethodOfAccountingAccrual>X</MethodOfAccountingAccrual>
      <AccountantCompileOrReview>0</AccountantCompileOrReview>
      <FSAudited>1</FSAudited>
      <FSAuditedBasis>
        <FinancialStatementSeparate>X</FinancialStatementSeparate>
      </FSAuditedBasis>
      <AuditCommittee>1</AuditCommittee>
      <FederalGrantAuditRequired>1</FederalGrantAuditRequired>
      <FederalGrantAuditPerformed>1</FederalGrantAuditPerformed>
    </IRS990>
    <IRS990ScheduleA documentId="RetDoc1039100001">
      <PubliclySupportedOrg170b1Avi>X</PubliclySupportedOrg170b1Avi>
      <GiftsGrantsContribReceived170>
        <CurrentTaxYearMinus4Years>1527886</CurrentTaxYearMinus4Years>
        <CurrentTaxYearMinus3Years>2189626</CurrentTaxYearMinus3Years>
        <CurrentTaxYearMinus2Years>2831952</CurrentTaxYearMinus2Years>
        <CurrentTaxYearMinus1Year>2654145</CurrentTaxYearMinus1Year>
        <CurrentTaxYear>3216510</CurrentTaxYear>
        <Total>12420119</Total>
      </GiftsGrantsContribReceived170>
      <Total170>
        <CurrentTaxYearMinus4Years>1527886</CurrentTaxYearMinus4Years>
        <CurrentTaxYearMinus3Years>2189626</CurrentTaxYearMinus3Years>
        <CurrentTaxYearMinus2Years>2831952</CurrentTaxYearMinus2Years>
        <CurrentTaxYearMinus1Year>2654145</CurrentTaxYearMinus1Year>
        <CurrentTaxYear>3216510</CurrentTaxYear>
        <Total>12420119</Total>
      </Total170>
      <PublicSupportTotal170>12420119</PublicSupportTotal170>
      <GrossInvestmentIncome170>
        <CurrentTaxYearMinus4Years>557</CurrentTaxYearMinus4Years>
        <CurrentTaxYearMinus3Years>1758</CurrentTaxYearMinus3Years>
        <CurrentTaxYearMinus2Years>2044</CurrentTaxYearMinus2Years>
        <CurrentTaxYearMinus1Year>1608</CurrentTaxYearMinus1Year>
        <CurrentTaxYear>373</CurrentTaxYear>
        <Total>6340</Total>
      </GrossInvestmentIncome170>
      <TotalSupport>12426459</TotalSupport>
      <GrossReceiptsFromAdmissionsEtc>705780</GrossReceiptsFromAdmissionsEtc>
      <PublicSupportPertcentage170>0.99950</PublicSupportPertcentage170>
      <PublicSupportPertcentPriorYear>0.99900</PublicSupportPertcentPriorYear>
      <ThirtyThreePercntTestsCY170>X</ThirtyThreePercntTestsCY170>
    </IRS990ScheduleA>
    <IRS990ScheduleB documentId="RetDoc1234500001">
      <ContributorInfo>
        <ContributorNumber>RESTRICTED</ContributorNumber>
        <ContributorNameBusiness>
          <BusinessNameLine1>RESTRICTED</BusinessNameLine1>
        </ContributorNameBusiness>
        <ContributorAddressUS>
          <AddressLine1>RESTRICTED</AddressLine1>
          <AddressLine2>RESTRICTED</AddressLine2>
          <City>RESTRICTED</City>
          <State>RESTRICTED</State>
          <ZIPCode>RESTRICTED</ZIPCode>
        </ContributorAddressUS>
        <AggregateContributions>RESTRICTED</AggregateContributions>
      </ContributorInfo>
    </IRS990ScheduleB>
    <IRS990ScheduleD documentId="RetDoc1040000001">
      <Equipment>
        <OtherCostOrOtherBasis>1445577</OtherCostOrOtherBasis>
        <Depreciation>910868</Depreciation>
        <BookValue>534709</BookValue>
      </Equipment>
      <TotalOfBookValueLandBuildings>534709</TotalOfBookValueLandBuildings>
      <OtherLiabilities>
        <Description>GRANT ADVANCES</Description>
        <Amount>912608</Amount>
      </OtherLiabilities>
      <TotalOfAmounts>912608</TotalOfAmounts>
      <FootnoteInPartXIII>X</FootnoteInPartXIII>
      <TotRevenueEtcAuditedFinclStmt>3239463</TotRevenueEtcAuditedFinclStmt>
      <RevenueNotRptdF990>0</RevenueNotRptdF990>
      <RevenueSubtotal>3239463</RevenueSubtotal>
      <RevenueNotRptdOnFinStmt>0</RevenueNotRptdOnFinStmt>
      <TotalRevenuePerForm990>3239463</TotalRevenuePerForm990>
      <TotExpensesEtcAuditedFinclStmt>3171866</TotExpensesEtcAuditedFinclStmt>
      <ExpensesNotRptdF990>0</ExpensesNotRptdF990>
      <ExpensesSubtotal>3171866</ExpensesSubtotal>
      <ExpensesNotRptdOnFinStmt>0</ExpensesNotRptdOnFinStmt>
      <TotalExpensesPerForm990>3171866</TotalExpensesPerForm990>
      <Form990ScheduleDPartXIII>
        <Identifier>DESCRIPTION OF UNCERTAIN TAX POSITIONS UNDER FIN 48:</Identifier>
        <ReturnReference>PART X, LINE 2:</ReturnReference>
        <Explanation>THE FOUNDATION FOLLOWS ACCOUNTING REQUIREMENTS ASSOCIATED WITH UNCERTAINTY IN INCOME TAXES USING THE PROVISIONS OF FINANCIAL ACCOUNTING STANDARDS BOARD (FASB) ASC 740, INCOME TAXES. USING THAT GUIDANCE, TAX POSITIONS INITIALLY NEED TO BE RECOGNIZED IN THE FINANCIAL STATEMENTS WHEN IT IS MORE-LIKELY-THAN-NOT THAT THE POSITIONS WILL NOT BE SUSTAINED UPON EXAMINATION BY THE TAX AUTHORITIES. IT ALSO PROVIDES GUIDANCE FOR DERECOGNITION, CLASSIFICATION, INTEREST AND PENALTIES, ACCOUNTING IN INTERIM PERIODS, DISCLOSURE AND TRANSITION. AS OF DECEMBER 31, 2012 AND 2011, THE FOUNDATION HAS NO UNCERTAIN TAX POSITIONS THAT QUALIFY FOR EITHER RECOGNITION OR DISCLOSURE IN THE FINANCIAL STATEMENTS. THE FOUDNATION BELIEVES IT IS NO LONGER SUBJECT TO INCOME TAX EXAMINATIONS FOR TAX YEARS PRIOR TO 2009.</Explanation>
      </Form990ScheduleDPartXIII>
    </IRS990ScheduleD>
    <IRS990ScheduleJ documentId="RetDoc1042400001">
      <BoardOrCommitteeApproval>X</BoardOrCommitteeApproval>
      <SeverancePayment>0</SeverancePayment>
      <SupplementalNonqualRetirePlan>0</SupplementalNonqualRetirePlan>
      <EquityBasedCompArrangement>0</EquityBasedCompArrangement>
      <CompBasedOnRevenueOfFilingOrg>0</CompBasedOnRevenueOfFilingOrg>
      <CompBasedOnRevenueRelatedOrgs>0</CompBasedOnRevenueRelatedOrgs>
      <CompBasedNetEarningsFilingOrg>0</CompBasedNetEarningsFilingOrg>
      <CompBasedNetEarningsRelateOrgs>0</CompBasedNetEarningsRelateOrgs>
      <AnyNonFixedPayments>0</AnyNonFixedPayments>
      <InitialContractException>0</InitialContractException>
      <Form990ScheduleJPartII>
        <NamePerson>STEVEN BENNER</NamePerson>
        <Title>DIRECTOR</Title>
        <BaseCompensationFilingOrg>170303</BaseCompensationFilingOrg>
        <CompBasedOnRelatedOrgs>0</CompBasedOnRelatedOrgs>
        <BonusFilingOrg>0</BonusFilingOrg>
        <BonusRelatedOrgs>0</BonusRelatedOrgs>
        <OtherCompensationFilingOrg>0</OtherCompensationFilingOrg>
        <OtherCompensationRelatedOrgs>0</OtherCompensationRelatedOrgs>
        <DeferredCompFilingOrg>0</DeferredCompFilingOrg>
        <DeferredCompRelatedOrgs>0</DeferredCompRelatedOrgs>
        <NontaxableBenefitsFilingOrg>0</NontaxableBenefitsFilingOrg>
        <NontaxableBenefitsRelatedOrgs>0</NontaxableBenefitsRelatedOrgs>
        <TotalCompensationFilingOrg>170303</TotalCompensationFilingOrg>
        <TotalCompensationRelatedOrgs>0</TotalCompensationRelatedOrgs>
        <CompReportPrior990FilingOrg>0</CompReportPrior990FilingOrg>
        <CompReportPrior990RelatedOrgs>0</CompReportPrior990RelatedOrgs>
      </Form990ScheduleJPartII>
    </IRS990ScheduleJ>
    <IRS990ScheduleL documentId="RetDoc1042800001">
      <Form990ScheduleLPartIV>
        <NameOfInterestedPerson>
          <NameBusiness>
            <BusinessNameLine1>NUCLEIC ACIDS LICENSING LLC</BusinessNameLine1>
          </NameBusiness>
        </NameOfInterestedPerson>
        <Relationship>OWNER</Relationship>
        <AmountOfTransaction>8284</AmountOfTransaction>
        <DescriptionOfTransaction>CONTRACT REVENUE</DescriptionOfTransaction>
        <SharingOfRevenues>0</SharingOfRevenues>
      </Form990ScheduleLPartIV>
    </IRS990ScheduleL>
    <IRS990ScheduleO documentId="RetDoc1044400001">
      <GeneralExplanation>
        <ReturnReference>FORM 990, PART VI, SECTION A, LINE 2</ReturnReference>
        <Explanation>RELATED PARTY INFORMATION AMONG OFFICERS STEVEN BENNER- PRESIDENT BEVERLY SANDERS- DIRECTOR MARRIED</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <ReturnReference>FORM 990, PART VI, SECTION B, LINE 11</ReturnReference>
        <Explanation>A COPY OF THE FORM 990 WILL BE PROVIDED TO THE GOVERNING BODY BEFORE IT IS FILED. IT WILL BE REVIEWED AND ANY NECESSARY CHANGES WILL BE MADE.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <ReturnReference>FORM 990, PART VI, SECTION B, LINE 12C</ReturnReference>
        <Explanation>THE BOARD ADDRESSES CONFLICTS OF INTEREST THROUGHOUT THE YEAR AS THE NEED ARISES.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <ReturnReference>FORM 990, PART VI, SECTION B, LINE 15</ReturnReference>
        <Explanation>A BOARD MEETING IS CALLED TO REVIEW PERFORMANCE OF THE PRIOR YEAR. BOARD MEMBERS DETERMINE ANY INCREASE AND VOTE ON THE INCREASE DETERMINED. THE APPLICABLE INCREASE IS APPLIED ONCE IT IS VOTED ON AND APPROVED BY THE BOARD.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <ReturnReference>FORM 990, PART VI, SECTION C, LINE 18</ReturnReference>
        <Explanation>GOVERNING DOCUMENTS ARE MADE AVAILABLE TO THE PUBLIC UPON REQUEST.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <ReturnReference>FORM 990, PART VI, SECTION C, LINE 19</ReturnReference>
        <Explanation>THE BOARD ADDRESSES THEIR CONFLICTS OF INTEREST THROUGHOUT THE YEAR AS THE NEED ARISES.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <ReturnReference>FORM 990 PART XII LINE 2C</ReturnReference>
        <Explanation>THE PROCESS FOR OVERSIGHT HAS NOT CHANGED IN THE CURRENT YEAR</Explanation>
      </GeneralExplanation>
    </IRS990ScheduleO>
    <IRS990ScheduleR documentId="RetDoc1043500001">
      <Form990ScheduleRPartIV>
        <NameOfRelatedOrg>
          <BusinessNameLine1>FIREBIRD BIOMOLECULAR SCIENCES LLC</BusinessNameLine1>
        </NameOfRelatedOrg>
        <AddressUS>
          <AddressLine1>2153 SE HAWTHORNE RD 116</AddressLine1>
          <City>GAINESVILLE</City>
          <State>FL</State>
          <ZIPCode>32641</ZIPCode>
        </AddressUS>
        <EIN>900355722</EIN>
        <PrimaryActivity>RESEARCH</PrimaryActivity>
        <LegalDomicileState>FL</LegalDomicileState>
        <DirectControllingEntityNA>N/A</DirectControllingEntityNA>
        <TypeOfEntity>C</TypeOfEntity>
        <ControlledOrg>0</ControlledOrg>
      </Form990ScheduleRPartIV>
      <Form990ScheduleRPartIV>
        <NameOfRelatedOrg>
          <BusinessNameLine1>NUCLEIC ACIDS LICENSING LLC</BusinessNameLine1>
        </NameOfRelatedOrg>
        <AddressUS>
          <AddressLine1>1501 NW 68TH TERRACE</AddressLine1>
          <City>GAINESVILLE</City>
          <State>FL</State>
          <ZIPCode>32605</ZIPCode>
        </AddressUS>
        <EIN>202709991</EIN>
        <PrimaryActivity>RESEARCH</PrimaryActivity>
        <LegalDomicileState>FL</LegalDomicileState>
        <DirectControllingEntityNA>N/A</DirectControllingEntityNA>
        <TypeOfEntity>C</TypeOfEntity>
        <ControlledOrg>0</ControlledOrg>
      </Form990ScheduleRPartIV>
      <ReceiptOfIntAnnRentsRoyalties>0</ReceiptOfIntAnnRentsRoyalties>
      <GiftGrantOrCapContrToOtherOrg>0</GiftGrantOrCapContrToOtherOrg>
      <GiftGrantOrCapContrFrOtherOrg>0</GiftGrantOrCapContrFrOtherOrg>
      <LoansOrGuaranteesToOtherOrg>0</LoansOrGuaranteesToOtherOrg>
      <LoansOrGuaranteesFromOtherOrg>0</LoansOrGuaranteesFromOtherOrg>
      <DividendsRelatedOrganization>0</DividendsRelatedOrganization>
      <SaleOfAssetsToOtherOrg>0</SaleOfAssetsToOtherOrg>
      <PurchaseOfAssetsFromOtherOrg>0</PurchaseOfAssetsFromOtherOrg>
      <ExchangeOfAssets>0</ExchangeOfAssets>
      <RentalOfFacilitiesToOtherOrgs>0</RentalOfFacilitiesToOtherOrgs>
      <RentalOfFacilitiesFrOtherOrgs>0</RentalOfFacilitiesFrOtherOrgs>
      <PerformOfServicesForOtherOrgs>0</PerformOfServicesForOtherOrgs>
      <PerformOfServicesByOtherOrgs>0</PerformOfServicesByOtherOrgs>
      <SharingOfFacilities>1</SharingOfFacilities>
      <SharingOfPaidEmployees>0</SharingOfPaidEmployees>
      <ReimbursementPaidToOtherOrg>0</ReimbursementPaidToOtherOrg>
      <ReimbursementPaidByOtherOrg>0</ReimbursementPaidByOtherOrg>
      <OtherTransferToOtherOrg>0</OtherTransferToOtherOrg>
      <OtherTransferFromOtherOrg>0</OtherTransferFromOtherOrg>
    </IRS990ScheduleR>
  </ReturnData>
</Return>